Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

ASIT Biotech S.A.. (1/25/18). "Press Release: ASIT Biotech Successfully Completes the First Tranche of Its Capital Increase and Raises €9.4 Million [Not for United States, Australia, Canada, Japan, et al.]". Brussels.

Organisations Organisation ASIT Biotech S.A. (Euronext: ASIT – BE0974289218)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product gp- ASIT+™ grass pollen rhinitis immunotherapy
  Product 2 investment banking
Index term Index term ASIT Biotech–SEVERAL: investment, 201801 private placement capital increase first tranche €9.4m w 2.46m new shares at €3.83/share
Persons Person Legon, Thierry (ASIT Biotech 201605 CEO)
  Person 2 Orešanský, Dušan (NewCap 201404)
     


   
Record changed: 2018-02-28

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for ASIT Biotech S.A. (Euronext: ASIT – BE0974289218)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe Spring 2019 Vienna Austria March 120x180px Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 120x180px